Clinical trials located in


Saint-Genis-Laval city is located in France. Currently, 1 clinical trials are being conducted in this city.

Saint-Genis-Laval, located in the Auvergne-Rhône-Alpes region of France, is a city rich in history and culture. It is known for its astronomical observatory, which has contributed significantly to the study of the stars since the 19th century. The city’s heritage is also marked by the presence of the Château de Beauregard, a testament to its historical significance. Surrounded by picturesque landscapes, Saint-Genis-Laval offers a blend of natural beauty and architectural marvels, reflecting the charm of French urban life while preserving its historical roots.

  • CT-EU-00116295

    Trial of KRT-232 and Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia

    This here clinical trial is looking at a new drug called KRT-232 for treating chronic myeloid leukemia, which is a type of blood cancer. The study aims to see if KRT-232, when taken along with other approved drugs like dasatinib or nilotinib, can help patients whose leukemia has come back or stopped responding to those other drugs.

    KRT-232 works by blocking a protein called MDM2, which normally keeps cancer cells alive. The main goals are to find the highest safe dose of KRT-232 that can be given with dasatinib or nilotinib, and to see if the combination can get patients’ leukemia under better control.

    This is an open-label study, meaning both patients and doctors know what treatment is being given. Patients must have chronic myeloid leukemia that has relapsed or become resistant to prior treatment with a tyrosine kinase inhibitor drug like dasatinib or nilotinib.

    • KRT-232
    • Dasatinib
    • Nilotinib

See more clinical trials in other cities in France: